Clinical Trial Update: S100A8 in Serum and Urine as a New Biomarker in Lupus Nephritis

View source ↗

Summary

This clinical trial update reports on S100A8 levels in serum and urine as a potential biomarker for lupus nephritis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Snippet

Sponsor: Theodor Bilharz Research Institute | Conditions: S100A8, Serum | Status: COMPLETED